Novartis Secures EU Approval for Itvisma® in SMA Novartis has announced that the European Commission (EC) has granted approval for Itvisma® (onasemnogene abeparvovec) for the treatment of children aged two…
Immunomic Therapeutics Doses First Participant in Phase 1 Trial of ITI-9001 Therapeutic Vaccine for Japanese Cedar Pollen Allergy Immunomic Therapeutics Inc. (ITI), a clinical-stage biotechnology company and subsidiary of HLB,…
Visby Medical Receives FDA Clearance for First At-Home Multi-Viral PCR Test for COVID-19 and Influenza Visby Medical, a company focused on developing rapid molecular diagnostics for use at home, has…
Arima Genomics Partners with Active Motif to Expand Access to Hi-C Research Technologies While Accelerating Clinical Cancer Diagnostics Strategy Arima Genomics, Inc., a biotechnology company focused on advancing precision oncology…
AGC Pharma Chemicals Validates New Barcelona CDMO Facility Through Scientist.com’s VERIF.i® Supplier Assessment Program AGC Pharma Chemicals, a leading global Contract Development and Manufacturing Organization (CDMO) specializing in small molecule…
PeptiDream Strengthens Executive Leadership Team with Three New Executive Vice Presidents to Accelerate Global Growth PeptiDream Inc., a publicly traded biopharmaceutical company headquartered in Kawasaki, Japan, has announced the appointment…
US Heart and Vascular Expands Georgia Presence Through Partnerships with Cardiovascular Clinic of North Georgia and Cardiology of Atlanta US Heart and Vascular, a national provider of administrative and operational…
Medical University of Graz Enrolls First Patient in DEEPER CHALLENGE Trial Evaluating Early Vessel Recoil in High-Risk CLTI Patients Reflow Medical, Inc. has announced the enrollment of the first participant…
Arcturus Therapeutics and Thermo Fisher Scientific Form Strategic Collaboration to Advance ARCT-032 for Cystic Fibrosis Through Phase 3 Development and Potential Commercialization Arcturus Therapeutics Holdings Inc., a clinical-stage messenger RNA…
Genentech Reports Positive Phase III Krascendo 1 Results Demonstrating Divarasib Improves Survival in Previously Treated KRAS G12C Non-Small Cell Lung Cancer Genentech, a member of the Roche Group, has announced…
VIVAZEN Welcomes DEA Scheduling of Synthetic 7-Hydroxymitragynine, Reinforces Commitment to Safe Botanical Wellness and Consumer Transparency VIVAZEN®, a leading botanical wellness company in the United States, has welcomed the recent…
Rezon Bio Appoints Dr. Hubert Scholze as Chief Business Officer to Drive Global Growth and Strengthen Biologics CDMO Capabilities Rezon Bio, a science-driven European contract development and manufacturing organization (CDMO)…